ヒト化抗ＥＭＡＰＩＩ治療抗体 - Allinaire Therapeutics, LLC

Title:

ヒト化抗ＥＭＡＰＩＩ治療抗体

Document Type and Number:

Japanese Patent JP2023533514

Kind Code:

A

Abstract:

本開示は、内皮単球活性化ポリペプチドＩＩに結合するモノクローナル抗体およびこれを使用した処置方法を提供する。【選択図】図１

More Like This:

JP7402223	Anti-FC Epsilon-R1 alpha (FCER1A) antibodies, bispecific antigen binding molecules that bind to FCER1A and CD3, and uses thereof
JP7323949	Flagellin fusion protein and use thereof
WO/2004/072286	SUBSTANCE SPECIFIC TO HUMAN PD-1

Inventors:

Hey Douglas W Pea
Berezovsky, Suzanne Yee
Knight, david
Hoang, Cushing
One, Jordon Kay

Application Number:

JP2023500292A

Publication Date:

August 03, 2023

Filing Date:

June 28, 2021

Export Citation:

Assignee:

Allinaire Therapeutics, LLC

International Classes:

C12N15/13; A61K39/395; A61P11/00; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08

Attorney, Agent or Firm:

Norito Yamao
Norifumi Tomita
Fumio Inai
Manami Sasakura
Yusuke Shirae

Previous Patent: Compositions and Related Methods for Supporting Companion Animals with Gastrointestinal Disorders

Next Patent: Identifying and managing cannibalistic advertising to improve the effectiveness of Internet advertis...